GC
USNA icon

Globeflex Capital’s Usana Health Sciences USNA Stock Holding History

Globeflex Capital’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-12
Closed -$1K – 537
2022
Q2 		$1K Hold
12
– – ﹤0.01% 478
2022
Q1 		$1K Hold
12
– – ﹤0.01% 468
2021
Q4 		$1K Sell
12
-1,260
-99% -$126K ﹤0.01% 455
2021
Q3 		$117K Sell
1,272
-4,816
-79% -$463K 0.03% 378
2021
Q2 		$624K Buy
6,088
+12
+0.2% +$1.21K 0.11% 264
2021
Q1 		$593K Hold
6,076
– – 0.11% 275
2020
Q4 		$468K Hold
6,076
– – 0.1% 300
2020
Q3 		$447K Hold
6,076
– – 0.12% 269
2020
Q2 		$446K Buy
+6,076
New +$477K 0.11% 295
2019
Q3 		– Sell
-11,928
Closed -$947K – 542
2019
Q2 		$947K Sell
11,928
-11
-0.1% -$872 0.2% 170
2019
Q1 		$1M Sell
11,939
-2,989
-20% -$312K 0.21% 154
2018
Q4 		$1.76M Buy
14,928
+3
+0% +$347 0.42% 58
2018
Q3 		$1.8M Sell
14,925
-208
-1% -$25.8K 0.35% 78
2018
Q2 		$1.75M Sell
15,133
-4,576
-23% -$501K 0.36% 78
2018
Q1 		$1.69M Sell
19,709
-2,520
-11% -$195K 0.36% 78
2017
Q4 		$1.65M Sell
22,229
-555
-2% -$37.1K 0.46% 51
2017
Q3 		$1.31M Hold
22,784
– – 0.37% 76
2017
Q2 		$1.46M Buy
22,784
+1,541
+7% +$95K 0.36% 94
2017
Q1 		$1.22M Buy
+21,243
New +$1.27M 0.29% 132
2016
Q1 		– Sell
-23,742
Closed -$1.52M – 497
2015
Q4 		$1.52M Buy
23,742
+9,992
+73% +$648K 0.4% 46
2015
Q3 		$921K Buy
+13,750
New +$972K 0.2% 175
2013
Q3 		– Sell
-47,922
Closed -$1.73M – 668
2013
Q2 		$1.73M Buy
+47,922
New +$1.46M 0.24% 128

Other funds holding USNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Globeflex Capital's USNA Position: Q3 2022 in Review

Globeflex Capital sold out of Usana Health Sciences (USNA) in Q3 2022, closing a stake of 12 shares — an estimated $1K sold.

Globeflex Capital first reported a position in USNA in Q2 2013 and held it in 22 quarters. The position peaked at $1.8M in Q3 2018. 172 funds tracked by Wall St. Rank hold USNA as of Q3 2022.

  • Globeflex Capital reported no remaining Usana Health Sciences position as of Q3 2022 after selling out during the quarter.
  • Globeflex Capital sold 12 Usana Health Sciences shares in Q3 2022, an estimated $1K.
  • Globeflex Capital first reported a position in Usana Health Sciences in Q2 2013 and held it in 22 quarters.
  • Globeflex Capital's Usana Health Sciences position peaked at $1.8M in Q3 2018.
  • 172 funds tracked by Wall St. Rank held Usana Health Sciences as of Q3 2022.

Based on Globeflex Capital's 13F filing for Q3 2022, filed 14 Nov 2022.